Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 22966 AL 22980

Beta-site APP-cleaving Enzyme-1 Inhibitory Role of Natural Flavonoids in the Treatment of Alzheimer's Disease

Singh S, Kushwaha V, Sisodia S, Kumar S, Sahu KK.

Cent Nerv Syst Agents Med Chem. 2025;25(1):39-48. doi: 10.2174/0118715249315049240710063455.

An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission

Akyuz E, Arulsamy A, Aslan FS, Sarisözen B, Guney B, Hekimoglu A, Yilmaz BN, Retinasamy T, Shaikh MF.

Mol Neurobiol. 2025 Feb;62(2):1631-1674. doi: 10.1007/s12035-024-04333-y. Epub 2024 Jul 16.

Recent Insights into the Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies

Anitha K, Singh MK, Kohat K, Sri Varshini T, Chenchula S, Padmavathi R, Amerneni LS, Vishnu Vardhan K, Mythili Bai K, Chavan MR, Bhatt S.

Mol Neurobiol. 2025 Feb;62(2):2314-2332. doi: 10.1007/s12035-024-04384-1. Epub 2024 Aug 5.

Tetrameric Transthyretin as a Protective Factor Against Alzheimer's Disease

Corino C, Aimo A, Luigetti M, Ciccone L, Ferrari Chen YF, Panichella G, Musetti V, Castiglione V, Vergaro G, Emdin M, Franzini M.

Mol Neurobiol. 2025 Mar;62(3):2945-2954. doi: 10.1007/s12035-024-04442-8. Epub 2024 Aug 27.

Cinnamic Acid Derivatives: Recent Discoveries and Development Strategies for Alzheimer's Disease

Liu Y, Zhang Z, Zhu Z, Yang Y, Peng W, Chen Q, Mak S, Tism KW, Pi R.

Mini Rev Med Chem. 2025;25(2):163-175. doi: 10.2174/0113895575330648240819112435.

Basic approach on the protective effects of hesperidin and naringin in Alzheimer's disease

Kuşi M, Becer E, Vatansever HS.

Nutr Neurosci. 2025 May;28(5):550-562. doi: 10.1080/1028415X.2024.2397136. Epub 2024 Sep 3.

Dissecting the immune response of CD4(+) T cells in Alzheimer's disease

Kostic M, Zivkovic N, Cvetanovic A, Basic J, Stojanovic I.

Rev Neurosci. 2024 Sep 3;36(2):139-168. doi: 10.1515/revneuro-2024-0090. Print 2025 Feb 25.

Epigallocatechin-3-Gallate Inhibits Oxidative Stress Through the Keap1/Nrf2 Signaling Pathway to Improve Alzheimer Disease

Tang S, Zhang Y, Botchway BOA, Wang X, Huang M, Liu X.

Mol Neurobiol. 2025 Mar;62(3):3493-3507. doi: 10.1007/s12035-024-04498-6. Epub 2024 Sep 20.

Harnessing the benefits of physical exercise-induced melatonin: a potential promising approach to combat Alzheimer's disease by targeting beta-amyloid (Aβ)

Bian R, Xiang L, Su Z.

Hormones (Athens). 2025 Mar;24(1):3-13. doi: 10.1007/s42000-024-00602-6. Epub 2024 Sep 23.

Molecular Therapeutics in Development to Treat Alzheimer's Disease

Tartaglia MC, Ingelsson M.

Mol Diagn Ther. 2025 Jan;29(1):9-24. doi: 10.1007/s40291-024-00738-6. Epub 2024 Sep 24.

Alzheimer's Disease Protein Targets: Comprehensive Review and Future Directions

Kumar BS, Dinesh BGH, Shajan SRO, Sadashivappa NM, Ammunje DN, Kunjiappan S, Theivendren P, Pavadai P.

Curr Pharm Des. 2025;31(17):1347-1369. doi: 10.2174/0113816128334916241006195142.

Efficacy And Safety of Dual Orexin Receptor Antagonist (DORA) For Sleep Disturbance in Patients With Alzheimer's Disease Dementia. A Review Article

Alshiban A, Hasoglu T, Oster J.

Am J Geriatr Psychiatry. 2025 Feb;33(2):209-218. doi: 10.1016/j.jagp.2024.09.016. Epub 2024 Oct 3.

Exploring Therapeutic Strategies: The Relationship between Metabolic Disorders and FOXO Signalling in Alzheimer's Disease

Kaur P, Khan H, Grewal AK, Dua K, Singh SK, Gupta G, Singh TG.

CNS Neurol Disord Drug Targets. 2025;24(3):196-207. doi: 10.2174/0118715273321002240919102841.

A Lipid-Raft Theory of Alzheimer's Disease

Rappoport A.

Annu Rev Biochem. 2025 Jun;94(1):387-416. doi: 10.1146/annurev-biochem-052024-115455. Epub 2024 Oct 30.

From defense to disease: IFITM3 in immunity and Alzheimer's disease

Kehs Z, Cross AC, Li YM.

Neurotherapeutics. 2025 Apr;22(3):e00482. doi: 10.1016/j.neurot.2024.e00482. Epub 2024 Nov 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias